| Q39494125 | Characteristics of liver cirrhosis in Italy: Evidence for a decreasing role of HCV aetiology |
| Q91822104 | Clinical outcomes in patients with hepatitis D, cirrhosis and persistent hepatitis B virus replication, and receiving long-term tenofovir or entecavir |
| Q31107505 | Epidemiological and clinical scenario of chronic liver diseases in Italy: Data from a multicenter nationwide survey |
| Q39494196 | Evolving clinical landscape of chronic hepatitis B: A multicenter Italian study |
| Q47573260 | Gender differences in chronic liver diseases in two cohorts of 2001 and 2014 in Italy |
| Q39494133 | Hepatitis delta infection in Italian patients: towards the end of the story? |
| Q34176625 | Increased serum reverse triiodothyronine levels at diagnosis of hepatocellular carcinoma in patients with compensated HCV-related liver cirrhosis. |
| Q39320945 | Italian consensus Guidelines for the management of hepatitis B virus infections in patients with rheumatoid arthritis |
| Q92992262 | Letter: clinical outcomes of patients with hepatitis D infection in the liver transplant setting-authors' reply |
| Q91587968 | NS5A Gene Analysis by Next Generation Sequencing in HCV Nosocomial Transmission Clusters of HCV Genotype 1b Infected Patients |
| Q38789871 | Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study |
| Q60730847 | Prise en charge de l’infection par le virus de l’hépatite B chez les patients atteints de polyarthrite rhumatoïde : conférence de consensus italienne |
| Q58802756 | Restored Function of HBV-Specific T Cells After Long-term Effective Therapy With Nucleos(t)ide Analogues |
| Q45729932 | Serum insulin-like growth factor I evaluation as a useful tool for predicting the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis: a prospective study. |
| Q45391959 | Statements from the Taormina expert meeting on occult hepatitis B virus infection |
| Q47580819 | Treatment of Acute Hepatitis C With Ledipasvir and Sofosbuvir in Patients With Hematological Malignancies Allows Early Re-start of Chemotherapy |